We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FIRM WANTS DNA GUIDELINES ADDED TO DRAFT GUIDANCE
FIRM WANTS DNA GUIDELINES ADDED TO DRAFT GUIDANCE
February 6, 2004
The FDA should include guidelines on the conditions and types of studies or study designs that would warrant DNA/RNA collection as part of its pharmacogenomics draft guidance, Johnson & Johnson (J&J) said in recent comments.